APO Research

APO RESEARCH · REPORT

Custom Oligo Synthesis

Selected research

Market Analysis & Forecast

Global Custom Oligo Synthesis Market Analysis and Forecast 2026-2032

Market perspective

The global Custom Oligo Synthesis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Custom Oligo Synthesis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Custom Oligo Synthesis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Custom Oligo Synthesis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Custom Oligo Synthesis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Custom Oligo Synthesis include Wuhan GeneCreate Biological Engineering, General Biol, Atantares, Beyotime, Thermo Fisher Scientific, Merck, Genscript, Guangzhou RiboBio and Tsingke, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Custom Oligo Synthesis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Custom Oligo Synthesis, also provides the revenue of main regions and countries. Of the upcoming market potential for Custom Oligo Synthesis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Custom Oligo Synthesis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Custom Oligo Synthesis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Custom Oligo Synthesis revenue, projected growth trends, production technology, application and end-user industry.

Custom Oligo Synthesis Segment by Company

Wuhan GeneCreate Biological Engineering

General Biol

Atantares

Beyotime

Thermo Fisher Scientific

Merck

Genscript

Guangzhou RiboBio

Tsingke

Abace Biotechnology

TriLink BioTechnologies

Synbio Technologies

Macrogen

Integrated DNA Technologies (IDT)

Eurogentec

Cusabio

BBI Life Sciences

Azenta Life Sciences

Aurigene Pharmaceutical Services

Custom Oligo Synthesis Segment by Type

Common Primer Synthesis

Modified Primer Synthesis

Custom Oligo Synthesis Segment by Application

Biotech Company

Academic Scientific Research Institution

Custom Oligo Synthesis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Oligo Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Oligo Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Oligo Synthesis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Custom Oligo Synthesis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Custom Oligo Synthesis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom Oligo Synthesis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Custom Oligo Synthesis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Common Primer Synthesis Major Player Table 3. Modified Primer Synthesis Major Player Table 4. Global Custom Oligo Synthesis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Biotech Company Major Player Table 6. Academic Scientific Research Institution Major Player Table 7. Custom Oligo Synthesis Industry Trends Table 8. Custom Oligo Synthesis Industry Drivers Table 9. Custom Oligo Synthesis Industry Opportunities and Challenges Table 10. Custom Oligo Synthesis Industry Restraints Table 11. Global Custom Oligo Synthesis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Custom Oligo Synthesis Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Custom Oligo Synthesis Market Share by Region (2021-2026) Table 14. Global Custom Oligo Synthesis Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Custom Oligo Synthesis Market Share by Region (2027-2032) Table 16. Global Custom Oligo Synthesis Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Custom Oligo Synthesis Revenue Market Share by Players (2021-2026) Table 18. Global Custom Oligo Synthesis Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Custom Oligo Synthesis Key Players Headquarters & Area Served Table 20. Global Custom Oligo Synthesis Players, Product Type & Application Table 21. Global Custom Oligo Synthesis Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Custom Oligo Synthesis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Custom Oligo Synthesis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Custom Oligo Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Custom Oligo Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Custom Oligo Synthesis Revenue Market Share by Type (2021-2026) Table 28. Global Custom Oligo Synthesis Revenue Market Share by Type (2027-2032) Table 29. Global Custom Oligo Synthesis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Custom Oligo Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Custom Oligo Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Custom Oligo Synthesis Revenue Market Share by Application (2021-2026) Table 33. Global Custom Oligo Synthesis Revenue Market Share by Application (2027-2032) Table 34. Wuhan GeneCreate Biological Engineering Company Information Table 35. Wuhan GeneCreate Biological Engineering Business Overview Table 36. Wuhan GeneCreate Biological Engineering Custom Oligo Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Wuhan GeneCreate Biological Engineering Custom Oligo Synthesis Product Portfolio Table 38. Wuhan GeneCreate Biological Engineering Recent Development Table 39. General Biol Company Information Table 40. General Biol Business Overview Table 41. General Biol Custom Oligo Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. General Biol Custom Oligo Synthesis Product Portfolio Table 43. General Biol Recent Development Table 44. Atantares Company Information Table 45. Atantares Business Overview Table 46. Atantares Custom Oligo Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Atantares Custom Oligo Synthesis Product Portfolio Table 48. Atantares Recent Development Table 49. Beyotime Company Information Table 50. Beyotime Business Overview Table 51. Beyotime Custom Oligo Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Beyotime Custom Oligo Synthesis Product Portfolio Table 53. Beyotime Recent Development Table 54. Thermo Fisher Scientific Company Information Table 55. Thermo Fisher Scientific Business Overview Table 56. Thermo Fisher Scientific Custom Oligo Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Thermo Fisher Scientific Custom Oligo Synthesis Product Portfolio Table 58. Thermo Fisher Scientific Recent Development Table 59. Merck Company Information Table 60. Merck Business Overview Table 61. Merck Custom Oligo Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Merck Custom Oligo Synthesis Product Portfolio Table 63. Merck Recent Development Table 64. Genscript Company Information Table 65. Genscript Business Overview Table 66. Genscript Custom Oligo Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Genscript Custom Oligo Synthesis Product Portfolio Table 68. Genscript Recent Development Table 69. Guangzhou RiboBio Company Information Table 70. Guangzhou RiboBio Business Overview Table 71. Guangzhou RiboBio Custom Oligo Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Guangzhou RiboBio Custom Oligo Synthesis Product Portfolio Table 73. Guangzhou RiboBio Recent Development Table 74. Tsingke Company Information Table 75. Tsingke Business Overview Table 76. Tsingke Custom Oligo Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Tsingke Custom Oligo Synthesis Product Portfolio Table 78. Tsingke Recent Development Table 79. Abace Biotechnology Company Information Table 80. Abace Biotechnology Business Overview Table 81. Abace Biotechnology Custom Oligo Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Abace Biotechnology Custom Oligo Synthesis Product Portfolio Table 83. Abace Biotechnology Recent Development Table 84. TriLink BioTechnologies Company Information Table 85. TriLink BioTechnologies Business Overview Table 86. TriLink BioTechnologies Custom Oligo Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. TriLink BioTechnologies Custom Oligo Synthesis Product Portfolio Table 88. TriLink BioTechnologies Recent Development Table 89. Synbio Technologies Company Information Table 90. Synbio Technologies Business Overview Table 91. Synbio Technologies Custom Oligo Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Synbio Technologies Custom Oligo Synthesis Product Portfolio Table 93. Synbio Technologies Recent Development Table 94. Macrogen Company Information Table 95. Macrogen Business Overview Table 96. Macrogen Custom Oligo Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Macrogen Custom Oligo Synthesis Product Portfolio Table 98. Macrogen Recent Development Table 99. Integrated DNA Technologies (IDT) Company Information Table 100. Integrated DNA Technologies (IDT) Business Overview Table 101. Integrated DNA Technologies (IDT) Custom Oligo Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Integrated DNA Technologies (IDT) Custom Oligo Synthesis Product Portfolio Table 103. Integrated DNA Technologies (IDT) Recent Development Table 104. Eurogentec Company Information Table 105. Eurogentec Business Overview Table 106. Eurogentec Custom Oligo Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Eurogentec Custom Oligo Synthesis Product Portfolio Table 108. Eurogentec Recent Development Table 109. Cusabio Company Information Table 110. Cusabio Business Overview Table 111. Cusabio Custom Oligo Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Cusabio Custom Oligo Synthesis Product Portfolio Table 113. Cusabio Recent Development Table 114. BBI Life Sciences Company Information Table 115. BBI Life Sciences Business Overview Table 116. BBI Life Sciences Custom Oligo Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. BBI Life Sciences Custom Oligo Synthesis Product Portfolio Table 118. BBI Life Sciences Recent Development Table 119. Azenta Life Sciences Company Information Table 120. Azenta Life Sciences Business Overview Table 121. Azenta Life Sciences Custom Oligo Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Azenta Life Sciences Custom Oligo Synthesis Product Portfolio Table 123. Azenta Life Sciences Recent Development Table 124. Aurigene Pharmaceutical Services Company Information Table 125. Aurigene Pharmaceutical Services Business Overview Table 126. Aurigene Pharmaceutical Services Custom Oligo Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Aurigene Pharmaceutical Services Custom Oligo Synthesis Product Portfolio Table 128. Aurigene Pharmaceutical Services Recent Development Table 129. North America Custom Oligo Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 130. North America Custom Oligo Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 131. North America Custom Oligo Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 132. North America Custom Oligo Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 133. North America Custom Oligo Synthesis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. North America Custom Oligo Synthesis Revenue by Country (2021-2026) & (US$ Million) Table 135. North America Custom Oligo Synthesis Revenue by Country (US$ Million) & (2027-2032) Table 136. Europe Custom Oligo Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Custom Oligo Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Custom Oligo Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 139. Europe Custom Oligo Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 140. Europe Custom Oligo Synthesis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Custom Oligo Synthesis Revenue by Country (2021-2026) & (US$ Million) Table 142. Europe Custom Oligo Synthesis Revenue by Country (US$ Million) & (2027-2032) Table 143. China Custom Oligo Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 144. China Custom Oligo Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 145. China Custom Oligo Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 146. China Custom Oligo Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Custom Oligo Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Custom Oligo Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Custom Oligo Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 150. Asia Custom Oligo Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Custom Oligo Synthesis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Custom Oligo Synthesis Revenue by Region (US$ Million) & (2021-2026) Table 153. Asia Custom Oligo Synthesis Revenue by Region (US$ Million) & (2027-2032) Table 154. SAMEA Custom Oligo Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 155. SAMEA Custom Oligo Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 156. SAMEA Custom Oligo Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 157. SAMEA Custom Oligo Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 158. SAMEA Custom Oligo Synthesis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. SAMEA Custom Oligo Synthesis Revenue by Country (2021-2026) & (US$ Million) Table 160. SAMEA Custom Oligo Synthesis Revenue by Country (US$ Million) & (2027-2032) Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Custom Oligo Synthesis Image Figure 2. Global Custom Oligo Synthesis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Oligo Synthesis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Common Primer Synthesis Image Figure 5. Modified Primer Synthesis Image Figure 6. Global Custom Oligo Synthesis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Custom Oligo Synthesis Market Size Share 2021 VS 2025 VS 2032 Figure 8. Biotech Company Image Figure 9. Academic Scientific Research Institution Image Figure 10. Global Custom Oligo Synthesis Market Size (US$ Million) & (2021-2032) Figure 11. Global Custom Oligo Synthesis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Custom Oligo Synthesis Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Custom Oligo Synthesis Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Custom Oligo Synthesis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Custom Oligo Synthesis Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Custom Oligo Synthesis Revenue Market Share by Type (2021-2032) Figure 18. Global Custom Oligo Synthesis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Custom Oligo Synthesis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Custom Oligo Synthesis Revenue Market Share by Application (2021-2032) Figure 21. North America Custom Oligo Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Custom Oligo Synthesis Revenue Share by Type (2021-2032) Figure 23. North America Custom Oligo Synthesis Revenue Share by Application (2021-2032) Figure 24. North America Custom Oligo Synthesis Revenue Share by Country (2021-2032) Figure 25. United States Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Custom Oligo Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Custom Oligo Synthesis Revenue Share by Type (2021-2032) Figure 30. Europe Custom Oligo Synthesis Revenue Share by Application (2021-2032) Figure 31. Europe Custom Oligo Synthesis Revenue Share by Country (2021-2032) Figure 32. Germany Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Custom Oligo Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Custom Oligo Synthesis Revenue Share by Type (2021-2032) Figure 42. China Custom Oligo Synthesis Revenue Share by Application (2021-2032) Figure 43. Asia Custom Oligo Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Custom Oligo Synthesis Revenue Share by Type (2021-2032) Figure 45. Asia Custom Oligo Synthesis Revenue Share by Application (2021-2032) Figure 46. Asia Custom Oligo Synthesis Revenue Share by Region (2021-2032) Figure 47. Japan Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Custom Oligo Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Custom Oligo Synthesis Revenue Share by Type (2021-2032) Figure 55. SAMEA Custom Oligo Synthesis Revenue Share by Application (2021-2032) Figure 56. SAMEA Custom Oligo Synthesis Revenue Share by Country (2021-2032) Figure 57. Brazil Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Custom Oligo Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Common Primer Synthesis
  • Modified Primer Synthesis
Applications
  • Biotech Company
  • Academic Scientific Research Institution
Companies covered
  • Wuhan GeneCreate Biological Engineering
  • General Biol
  • Atantares
  • Beyotime
  • Thermo Fisher Scientific
  • Merck
  • Genscript
  • Guangzhou RiboBio
  • Tsingke
  • Abace Biotechnology
  • TriLink BioTechnologies
  • Synbio Technologies
  • Macrogen
  • Integrated DNA Technologies (IDT)
  • Eurogentec
  • Cusabio
  • BBI Life Sciences
  • Azenta Life Sciences
  • Aurigene Pharmaceutical Services

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Custom Oligo Synthesis Market by Type
  3. 1.2.1 Global Custom Oligo Synthesis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Common Primer Synthesis
  5. 1.2.3 Modified Primer Synthesis
  6. 1.3 Custom Oligo Synthesis Market by Application
  7. 1.3.1 Global Custom Oligo Synthesis Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Biotech Company
  9. 1.3.3 Academic Scientific Research Institution
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Custom Oligo Synthesis Market Dynamics
  1. 2.1 Custom Oligo Synthesis Industry Trends
  2. 2.2 Custom Oligo Synthesis Industry Drivers
  3. 2.3 Custom Oligo Synthesis Industry Opportunities and Challenges
  4. 2.4 Custom Oligo Synthesis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Custom Oligo Synthesis Market Perspective (2021-2032)
  2. 3.2 Global Custom Oligo Synthesis Growth Trends by Region
  3. 3.2.1 Global Custom Oligo Synthesis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Custom Oligo Synthesis Market Size by Region (2021-2026)
  5. 3.2.3 Global Custom Oligo Synthesis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Custom Oligo Synthesis Revenue by Players
  2. 4.1.1 Global Custom Oligo Synthesis Revenue by Players (2021-2026)
  3. 4.1.2 Global Custom Oligo Synthesis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Custom Oligo Synthesis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Custom Oligo Synthesis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Custom Oligo Synthesis Key Players Headquarters & Area Served
  7. 4.4 Global Custom Oligo Synthesis Players, Product Type & Application
  8. 4.5 Global Custom Oligo Synthesis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Custom Oligo Synthesis Market CR5 and HHI
  11. 4.6.3 2025 Custom Oligo Synthesis Tier 1, Tier 2, and Tier 3
5 Custom Oligo Synthesis Market Size by Type
  1. 5.1 Global Custom Oligo Synthesis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Custom Oligo Synthesis Revenue by Type (2021-2032)
  3. 5.3 Global Custom Oligo Synthesis Revenue Market Share by Type (2021-2032)
6 Custom Oligo Synthesis Market Size by Application
  1. 6.1 Global Custom Oligo Synthesis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Custom Oligo Synthesis Revenue by Application (2021-2032)
  3. 6.3 Global Custom Oligo Synthesis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Wuhan GeneCreate Biological Engineering
  2. 7.1.1 Wuhan GeneCreate Biological Engineering Company Information
  3. 7.1.2 Wuhan GeneCreate Biological Engineering Business Overview
  4. 7.1.3 Wuhan GeneCreate Biological Engineering Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Wuhan GeneCreate Biological Engineering Custom Oligo Synthesis Product Portfolio
  6. 7.1.5 Wuhan GeneCreate Biological Engineering Recent Developments
  7. 7.2 General Biol
  8. 7.2.1 General Biol Company Information
  9. 7.2.2 General Biol Business Overview
  10. 7.2.3 General Biol Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 General Biol Custom Oligo Synthesis Product Portfolio
  12. 7.2.5 General Biol Recent Developments
  13. 7.3 Atantares
  14. 7.3.1 Atantares Company Information
  15. 7.3.2 Atantares Business Overview
  16. 7.3.3 Atantares Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Atantares Custom Oligo Synthesis Product Portfolio
  18. 7.3.5 Atantares Recent Developments
  19. 7.4 Beyotime
  20. 7.4.1 Beyotime Company Information
  21. 7.4.2 Beyotime Business Overview
  22. 7.4.3 Beyotime Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Beyotime Custom Oligo Synthesis Product Portfolio
  24. 7.4.5 Beyotime Recent Developments
  25. 7.5 Thermo Fisher Scientific
  26. 7.5.1 Thermo Fisher Scientific Company Information
  27. 7.5.2 Thermo Fisher Scientific Business Overview
  28. 7.5.3 Thermo Fisher Scientific Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Thermo Fisher Scientific Custom Oligo Synthesis Product Portfolio
  30. 7.5.5 Thermo Fisher Scientific Recent Developments
  31. 7.6 Merck
  32. 7.6.1 Merck Company Information
  33. 7.6.2 Merck Business Overview
  34. 7.6.3 Merck Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Merck Custom Oligo Synthesis Product Portfolio
  36. 7.6.5 Merck Recent Developments
  37. 7.7 Genscript
  38. 7.7.1 Genscript Company Information
  39. 7.7.2 Genscript Business Overview
  40. 7.7.3 Genscript Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Genscript Custom Oligo Synthesis Product Portfolio
  42. 7.7.5 Genscript Recent Developments
  43. 7.8 Guangzhou RiboBio
  44. 7.8.1 Guangzhou RiboBio Company Information
  45. 7.8.2 Guangzhou RiboBio Business Overview
  46. 7.8.3 Guangzhou RiboBio Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Guangzhou RiboBio Custom Oligo Synthesis Product Portfolio
  48. 7.8.5 Guangzhou RiboBio Recent Developments
  49. 7.9 Tsingke
  50. 7.9.1 Tsingke Company Information
  51. 7.9.2 Tsingke Business Overview
  52. 7.9.3 Tsingke Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Tsingke Custom Oligo Synthesis Product Portfolio
  54. 7.9.5 Tsingke Recent Developments
  55. 7.10 Abace Biotechnology
  56. 7.10.1 Abace Biotechnology Company Information
  57. 7.10.2 Abace Biotechnology Business Overview
  58. 7.10.3 Abace Biotechnology Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Abace Biotechnology Custom Oligo Synthesis Product Portfolio
  60. 7.10.5 Abace Biotechnology Recent Developments
  61. 7.11 TriLink BioTechnologies
  62. 7.11.1 TriLink BioTechnologies Company Information
  63. 7.11.2 TriLink BioTechnologies Business Overview
  64. 7.11.3 TriLink BioTechnologies Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  65. 7.11.4 TriLink BioTechnologies Custom Oligo Synthesis Product Portfolio
  66. 7.11.5 TriLink BioTechnologies Recent Developments
  67. 7.12 Synbio Technologies
  68. 7.12.1 Synbio Technologies Company Information
  69. 7.12.2 Synbio Technologies Business Overview
  70. 7.12.3 Synbio Technologies Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Synbio Technologies Custom Oligo Synthesis Product Portfolio
  72. 7.12.5 Synbio Technologies Recent Developments
  73. 7.13 Macrogen
  74. 7.13.1 Macrogen Company Information
  75. 7.13.2 Macrogen Business Overview
  76. 7.13.3 Macrogen Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Macrogen Custom Oligo Synthesis Product Portfolio
  78. 7.13.5 Macrogen Recent Developments
  79. 7.14 Integrated DNA Technologies (IDT)
  80. 7.14.1 Integrated DNA Technologies (IDT) Company Information
  81. 7.14.2 Integrated DNA Technologies (IDT) Business Overview
  82. 7.14.3 Integrated DNA Technologies (IDT) Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Integrated DNA Technologies (IDT) Custom Oligo Synthesis Product Portfolio
  84. 7.14.5 Integrated DNA Technologies (IDT) Recent Developments
  85. 7.15 Eurogentec
  86. 7.15.1 Eurogentec Company Information
  87. 7.15.2 Eurogentec Business Overview
  88. 7.15.3 Eurogentec Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Eurogentec Custom Oligo Synthesis Product Portfolio
  90. 7.15.5 Eurogentec Recent Developments
  91. 7.16 Cusabio
  92. 7.16.1 Cusabio Company Information
  93. 7.16.2 Cusabio Business Overview
  94. 7.16.3 Cusabio Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Cusabio Custom Oligo Synthesis Product Portfolio
  96. 7.16.5 Cusabio Recent Developments
  97. 7.17 BBI Life Sciences
  98. 7.17.1 BBI Life Sciences Company Information
  99. 7.17.2 BBI Life Sciences Business Overview
  100. 7.17.3 BBI Life Sciences Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  101. 7.17.4 BBI Life Sciences Custom Oligo Synthesis Product Portfolio
  102. 7.17.5 BBI Life Sciences Recent Developments
  103. 7.18 Azenta Life Sciences
  104. 7.18.1 Azenta Life Sciences Company Information
  105. 7.18.2 Azenta Life Sciences Business Overview
  106. 7.18.3 Azenta Life Sciences Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Azenta Life Sciences Custom Oligo Synthesis Product Portfolio
  108. 7.18.5 Azenta Life Sciences Recent Developments
  109. 7.19 Aurigene Pharmaceutical Services
  110. 7.19.1 Aurigene Pharmaceutical Services Company Information
  111. 7.19.2 Aurigene Pharmaceutical Services Business Overview
  112. 7.19.3 Aurigene Pharmaceutical Services Custom Oligo Synthesis Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Aurigene Pharmaceutical Services Custom Oligo Synthesis Product Portfolio
  114. 7.19.5 Aurigene Pharmaceutical Services Recent Developments
8 North America
  1. 8.1 North America Custom Oligo Synthesis Revenue (2021-2032)
  2. 8.2 North America Custom Oligo Synthesis Revenue by Type (2021-2032)
  3. 8.2.1 North America Custom Oligo Synthesis Revenue by Type (2021-2026)
  4. 8.2.2 North America Custom Oligo Synthesis Revenue by Type (2027-2032)
  5. 8.3 North America Custom Oligo Synthesis Revenue Share by Type (2021-2032)
  6. 8.4 North America Custom Oligo Synthesis Revenue by Application (2021-2032)
  7. 8.4.1 North America Custom Oligo Synthesis Revenue by Application (2021-2026)
  8. 8.4.2 North America Custom Oligo Synthesis Revenue by Application (2027-2032)
  9. 8.5 North America Custom Oligo Synthesis Revenue Share by Application (2021-2032)
  10. 8.6 North America Custom Oligo Synthesis Revenue by Country
  11. 8.6.1 North America Custom Oligo Synthesis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Custom Oligo Synthesis Revenue by Country (2021-2026)
  13. 8.6.3 North America Custom Oligo Synthesis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Custom Oligo Synthesis Revenue (2021-2032)
  2. 9.2 Europe Custom Oligo Synthesis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Custom Oligo Synthesis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Custom Oligo Synthesis Revenue by Type (2027-2032)
  5. 9.3 Europe Custom Oligo Synthesis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Custom Oligo Synthesis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Custom Oligo Synthesis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Custom Oligo Synthesis Revenue by Application (2027-2032)
  9. 9.5 Europe Custom Oligo Synthesis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Custom Oligo Synthesis Revenue by Country
  11. 9.6.1 Europe Custom Oligo Synthesis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Custom Oligo Synthesis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Custom Oligo Synthesis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Custom Oligo Synthesis Revenue (2021-2032)
  2. 10.2 China Custom Oligo Synthesis Revenue by Type (2021-2032)
  3. 10.2.1 China Custom Oligo Synthesis Revenue by Type (2021-2026)
  4. 10.2.2 China Custom Oligo Synthesis Revenue by Type (2027-2032)
  5. 10.3 China Custom Oligo Synthesis Revenue Share by Type (2021-2032)
  6. 10.4 China Custom Oligo Synthesis Revenue by Application (2021-2032)
  7. 10.4.1 China Custom Oligo Synthesis Revenue by Application (2021-2026)
  8. 10.4.2 China Custom Oligo Synthesis Revenue by Application (2027-2032)
  9. 10.5 China Custom Oligo Synthesis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Custom Oligo Synthesis Revenue (2021-2032)
  2. 11.2 Asia Custom Oligo Synthesis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Custom Oligo Synthesis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Custom Oligo Synthesis Revenue by Type (2027-2032)
  5. 11.3 Asia Custom Oligo Synthesis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Custom Oligo Synthesis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Custom Oligo Synthesis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Custom Oligo Synthesis Revenue by Application (2027-2032)
  9. 11.5 Asia Custom Oligo Synthesis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Custom Oligo Synthesis Revenue by Country
  11. 11.6.1 Asia Custom Oligo Synthesis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Custom Oligo Synthesis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Custom Oligo Synthesis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Custom Oligo Synthesis Revenue (2021-2032)
  2. 12.2 SAMEA Custom Oligo Synthesis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Custom Oligo Synthesis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Custom Oligo Synthesis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Custom Oligo Synthesis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Custom Oligo Synthesis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Custom Oligo Synthesis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Custom Oligo Synthesis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Custom Oligo Synthesis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Custom Oligo Synthesis Revenue by Country
  11. 12.6.1 SAMEA Custom Oligo Synthesis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Custom Oligo Synthesis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Custom Oligo Synthesis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research